Dynamics of Changes in Self-Efficacy and Locus of Control Expectancies in the Behavioral and Drug Treatment of Severe Migraine

被引:41
作者
Seng, Elizabeth K. [1 ]
Holroyd, Kenneth A. [1 ]
机构
[1] Ohio Univ, Dept Psychol, Athens, OH 45701 USA
基金
美国国家卫生研究院;
关键词
Migraine; Behavioral treatment; Drug treatment; Self-efficacy; Locus of control; Socioeconomic status; THERMAL BIOFEEDBACK TREATMENT; COGNITIVE CHANGES; CHANGE MECHANISMS; CLINICAL-TRIALS; HEADACHE; TOPIRAMATE; MANAGEMENT; PLACEBO; HEALTH; PSYCHOTHERAPY;
D O I
10.1007/s12160-010-9223-3
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background Modification of expectancies (headache self-efficacy and headache locus of control) is thought to be central to the success of psychological treatments for migraine. Purpose The purpose of this study is to examine expectancy changes with various combinations of Behavioral Migraine Management and migraine drug therapies. Methods Frequent migraine sufferers who failed to respond to 5 weeks of optimized acute migraine drug therapy were randomized to a 2 (Behavioral Migraine Management+, Behavioral Migraine Management-) x 2 (beta-blocker, placebo) treatment design. Results Mixed models for repeated measures analyses (N= 176) revealed large increases in headache self-efficacy and internal headache locus of control and large decreases in chance headache locus of control with Behavioral Migraine Management+ that were maintained over a 12-month evaluation period. Chance headache locus of control and socioeconomic status moderated changes in headache self-efficacy with Behavioral Migraine Management+. Conclusions The "deficiency" hypothesis best explained how patient characteristics influenced changes in of headache self-efficacy with Behavioral Migraine Management.
引用
收藏
页码:235 / 247
页数:13
相关论文
共 58 条
  • [1] [Anonymous], SELF MANAGEMENT CHRO
  • [2] [Anonymous], STANDARDS CARE HEADA
  • [3] SELF-EFFICACY - TOWARD A UNIFYING THEORY OF BEHAVIORAL CHANGE
    BANDURA, A
    [J]. PSYCHOLOGICAL REVIEW, 1977, 84 (02) : 191 - 215
  • [4] Bandura A., 1997, SELF EFFICACY EXERCI
  • [5] The impact of missing data and how it is handled on the rate of false-positive results in drug development
    Barnes, Sunni A.
    Mallinckrodt, Craig H.
    Lindborg, Stacy R.
    Carter, M. Kallin
    [J]. PHARMACEUTICAL STATISTICS, 2008, 7 (03) : 215 - 225
  • [6] BLANCHARD EB, 1994, HEADACHE Q-CURR TREA, V5, P231
  • [7] Patient self-management of chronic disease in primary care
    Bodenheimer, T
    Lorig, K
    Holman, H
    Grumbach, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (19): : 2469 - 2475
  • [8] The migraine cycle: Patient burden of migraine during and between migraine attacks
    Brandes, Jan Lewis
    [J]. HEADACHE, 2008, 48 (03): : 430 - 441
  • [9] Topiramate for migraine prevention - A randomized controlled trial
    Brandes, JL
    Saper, JR
    Diamond, M
    Couch, JR
    Lewis, DW
    Schmitt, J
    Neto, W
    Schwabe, S
    Jacobs, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (08): : 965 - 973
  • [10] Campbell JK., 2000, Evidence-based guidelines for migraine headache: behavioral and physical treatments